Lin MH, et al. Real-world brigatinib use in non-small cell lung cancer patients with prior use of crizotinib/other ALK therapies in the US. Abstract P2.16-09. WCLC 2019, 7-10 sept. Barcelona, Spanje.
Gestage groei aantal patiënten met kanker in Nederland
feb 2017 | Borstkanker, Longoncologie, Maag-darm-leveroncologie